These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15262095)

  • 1. Pulmonary embolism.
    Robinson G
    Lancet; 2004 Jul 17-23; 364(9430):244. PubMed ID: 15262095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombosis--adverse effect of drugs].
    Ota S; Yamada N; Nakano T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():450-4. PubMed ID: 18074580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Picture of the month: pulmonary artery embolism, deep venous thrombosis].
    Isaksen CR
    Ugeskr Laeger; 2005 Apr; 167(17):1867. PubMed ID: 15929338
    [No Abstract]   [Full Text] [Related]  

  • 4. Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism.
    Jick SS
    Evid Based Nurs; 2014 Jul; 17(3):71. PubMed ID: 24170817
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracardiac entrapped and pulmonary embolism developing during oral contraceptive therapy in a young woman.
    Erkut B; Ates A; Arslan S
    J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):297-8. PubMed ID: 20019620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is non-oral hormonal contraception really free of risks? Comment on the case report by Spinner et al].
    Thomssen C
    Internist (Berl); 2012 Aug; 53(8):982-4. PubMed ID: 22825782
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review".
    Cameron S
    BJOG; 2013 Jun; 120(7):811. PubMed ID: 23802311
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary side effects of oral steroid contraceptives].
    Lingard W; Morawetz F
    Wien Med Wochenschr; 1976 Nov; 126(45):631-3. PubMed ID: 1007292
    [No Abstract]   [Full Text] [Related]  

  • 9. [A young woman with fulminant pulmonary embolism].
    Spinner T; Segerer M; Holub A; Spes C; Mudra H
    Internist (Berl); 2012 Aug; 53(8):985-9. PubMed ID: 22674450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PULMONARY THROMBOEMBOLISM IN WOMEN USING ORAL HORMONAL CONTRACEPTIVES].
    Ovchinnikov YV; Panfilov DN; Zelenov MV; Suvorov VV; Popov AV
    Klin Med (Mosk); 2015; 93(10):58-66. PubMed ID: 26964468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraceptive agents and coronary disease].
    Kjeldaas L; Borchgrevink CF
    Nord Med; 1985; 100(10):269. PubMed ID: 3831939
    [No Abstract]   [Full Text] [Related]  

  • 12. Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel?
    Rosa MI; Madeira K; Medeiros LR
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):137-9. PubMed ID: 23496252
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.
    Martínez F; Latorre K; Ramírez I; Pérez-Campos E; Lete I
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):139-42. PubMed ID: 23496253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral contraceptives increase deep venous thrombosis in smoking women].
    Tsankova V; Petrov V; Astrug A
    Akush Ginekol (Sofiia); 2010; 49(5):8-13. PubMed ID: 21268396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP; Rosenberg L; Kaufman DW; Strom B; Shapiro S
    Obstet Gynecol; 1987 Jan; 69(1):91-5. PubMed ID: 3796927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heavy legs, venous insufficiency of the legs and hormone substitution therapy].
    Haesler E; Hayoz D
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1098-104. PubMed ID: 11367592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary embolism mortality in relation to oral contraceptive use.
    Sartwell PE; Stolley PD; Tonascia JA; Tockman MS; Rutledge AH; Wertheimer D
    Prev Med; 1976 Mar; 5(1):15-9. PubMed ID: 1264964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.